Sana Biotechnology shareholders elect all three Class III directors and ratify EY as auditor

Sana Biotechnology, Inc.

Joshua H. Bilenker, M.D. elected with ~149M votes for, ~16M withheld.
Richard Mulligan, Ph.D. elected with ~149.6M votes for, ~14.9M withheld.
Mary Agnes (Maggie) Wilderotter elected with ~144.2M votes for, ~20.3M withheld.
Ratification of Ernst & Young LLP as independent auditor for FY2024 passed with ~178.5M for, ~65K against.
Annual meeting held June 6, 2024; all proposals approved as recommended.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.